• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    118.90 Up 1.16(0.99%) Dec 19, 4:00PM EST
    |After Hours : 119.36 Up 0.46 (0.39%) Dec 19, 7:08PM EST
    Add to Portfolio
    Prev Close:117.74
    Open:117.25
    Bid:N/A
    Ask:122.60 x 300
    1y Target Est:125.27
    Beta:-1.01
    Earnings Date:Jan 27 - Feb 2 (Est.)
    Day's Range:116.76 - 124.35
    52wk Range:59.79 - 124.35
    Volume:6,131,369
    Avg Vol (3m):1,734,840
    Market Cap:28.60B
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXUp 0.99%28.60B
    BMYUp 0.84%101.68B
    MRKUp 1.02%169.86B
    PTCTUp 3.15%1.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-3.04
    Quarterly EPS Est (Dec-14) :-0.67
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-2.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback